JPS55154917A - Analgesic mixture - Google Patents

Analgesic mixture

Info

Publication number
JPS55154917A
JPS55154917A JP6469980A JP6469980A JPS55154917A JP S55154917 A JPS55154917 A JP S55154917A JP 6469980 A JP6469980 A JP 6469980A JP 6469980 A JP6469980 A JP 6469980A JP S55154917 A JPS55154917 A JP S55154917A
Authority
JP
Japan
Prior art keywords
analgesic mixture
analgesic
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP6469980A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0144684B2 (enExample
Inventor
Reimondo Dadojinsukii Jiyon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EIDP Inc
Original Assignee
EI Du Pont de Nemours and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EI Du Pont de Nemours and Co filed Critical EI Du Pont de Nemours and Co
Publication of JPS55154917A publication Critical patent/JPS55154917A/ja
Publication of JPH0144684B2 publication Critical patent/JPH0144684B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP6469980A 1979-05-18 1980-05-17 Analgesic mixture Granted JPS55154917A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/040,281 US4237140A (en) 1979-05-18 1979-05-18 Analgesic mixture of nalbuphine and acetaminophen

Publications (2)

Publication Number Publication Date
JPS55154917A true JPS55154917A (en) 1980-12-02
JPH0144684B2 JPH0144684B2 (enExample) 1989-09-29

Family

ID=21910135

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6469980A Granted JPS55154917A (en) 1979-05-18 1980-05-17 Analgesic mixture

Country Status (12)

Country Link
US (1) US4237140A (enExample)
EP (1) EP0019282B1 (enExample)
JP (1) JPS55154917A (enExample)
AU (1) AU529764B2 (enExample)
CA (1) CA1139671A (enExample)
DE (1) DE3061597D1 (enExample)
HU (1) HU178867B (enExample)
IE (1) IE49988B1 (enExample)
IL (1) IL60095A (enExample)
NZ (1) NZ193695A (enExample)
PH (1) PH15265A (enExample)
ZA (1) ZA802916B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0648944A (ja) * 1985-12-02 1994-02-22 Du Pont Merck Pharmaceut Co 経口投与のための鎮痛剤
USRE39221E1 (en) 1991-09-06 2006-08-01 Ortho-Mcneil Pharmaceutical, Inc. Composition comprising a tramadol material and acetaminophen and its use
JP2021535216A (ja) * 2018-09-03 2021-12-16 ジェイコブ バイオテック リミテッド セバコイルジナルブフィンとアセトアミノフェンの医薬品製剤及び疼痛を治療する方法

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
US4366159A (en) * 1981-09-08 1982-12-28 Michael Richard Magruder Nalbuphine-narcotic analgesic composition and method of producing analgesia
US4404211A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and flurbiprofen
US4407804A (en) * 1982-06-30 1983-10-04 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and indomethacin
US4404209A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and sulindac
US4404210A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and ibuprofen
US4404208A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and tiflamizole
US4407805A (en) * 1982-06-30 1983-10-04 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and zomepirac
US4402962A (en) * 1982-06-30 1983-09-06 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and 4,5-bis(4-methoxyphenyl)-2-(trifluoromethylsulfonyl)-1H-imidazole
AU565634B2 (en) * 1982-06-30 1987-09-24 E.I. Du Pont De Nemours And Company Synergistic compositions of nalbuphine and non-narcotic analgesic compounds
US4656177A (en) * 1982-07-22 1987-04-07 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4777174A (en) * 1982-07-22 1988-10-11 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
ZA835324B (en) * 1982-07-22 1984-09-26 Abraham Sunshine Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4600579A (en) * 1983-06-07 1986-07-15 Mallinckrodt, Inc. N-acetyl-p-aminophenol compositions containing partially gelatinized starch and method for preparing same
US5558876A (en) * 1995-03-29 1996-09-24 Alcon Laboratories, Inc. Topical ophthalmic acidic drug formulations
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
EP2266564B1 (en) 1997-12-22 2013-03-13 Euro-Celtique S.A. Pharmaceutical oral dosage form comprising a combination of an opioid agonist and an opioid antagonist
EP2517710B1 (en) 2000-02-08 2015-03-25 Euro-Celtique S.A. Tamper-resistant oral opioid agonist formulations
JP4522652B2 (ja) 2001-05-11 2010-08-11 エンドー ファーマシューティカルズ， インコーポレイティド 乱用防止制御放出オピオイド投薬形態
CA2454328C (en) 2001-07-18 2008-03-18 Christopher D. Breder Pharmaceutical combinations of oxycodone and naloxone
MXPA04001210A (es) * 2001-08-06 2004-07-08 Euro Celtique Sa Formulaciones de agonista opioide con antagonista liberable y aislado.
US20030157168A1 (en) 2001-08-06 2003-08-21 Christopher Breder Sequestered antagonist formulations
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
LT2425824T (lt) 2002-04-05 2017-07-25 Euro-Celtique S.A. Farmacinis preparatas, turintis oksikodono ir naloksono
SI1551372T1 (en) 2002-09-20 2018-08-31 Alpharma Pharmaceuticals Llc SUBVENCATION DATA AND RELATED CONSTRUCTIONS AND PROCEDURES
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
MY135852A (en) 2003-04-21 2008-07-31 Euro Celtique Sa Pharmaceutical products
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
US8394812B2 (en) 2005-08-24 2013-03-12 Penwest Pharmaceuticals Co. Sustained release formulations of nalbuphine
PT1931315E (pt) * 2005-08-24 2014-01-03 Endo Pharmaceuticals Inc Formulações de libertação sustentada de nalbufina
EP2719378B1 (en) 2006-06-19 2016-08-31 Alpharma Pharmaceuticals LLC Pharmaceutical compositions
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
HUE042105T2 (hu) 2009-03-10 2019-06-28 Euro Celtique Sa Oxikodont és naloxont tartalmazó azonnali hatóanyagleadású orális gyógyászati készítmények
EP3024461B1 (en) 2013-07-23 2020-05-13 Euro-Celtique S.A. A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
EP3086793B1 (en) 2013-12-24 2022-05-11 Virginia Commonwealth University Use of oxygenated cholesterol sulfates (ocs) for the treatment of kidney dysfunction
JOP20190094A1 (ar) * 2016-10-27 2019-04-25 Broad Inst Inc مركبات 1، 2، 4-تريازولون تحمل ثلاثة بدائل عند المواقع 2، 4، 5 مفيدة كمثبطات لديهيدروجيناز ثنائي هيدرو أوروتات (dhodh)
US11260048B2 (en) 2017-10-03 2022-03-01 The Schepens Eye Research Institute, Inc. Compounds and compositions for inhibiting retinal pigment epithelium degeneration and methods using the same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393197A (en) * 1966-01-19 1968-07-16 Endo Lab Nu-substituted-14-hydroxydihydronormorphines
JPS51142544A (en) * 1975-06-02 1976-12-08 Sumitomo Chem Co Ltd An anodyne comprising an indole acetic acid derivative,and a narcotic onarcotic or narcotic competitive analgestic compound as chief compone nts
JPS5283937A (en) * 1976-01-01 1977-07-13 Kaken Pharmaceut Co Ltd Antiphlogistic and analgesic agent containing benzoyl derivatives as e ffective component

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393197A (en) * 1966-01-19 1968-07-16 Endo Lab Nu-substituted-14-hydroxydihydronormorphines
JPS51142544A (en) * 1975-06-02 1976-12-08 Sumitomo Chem Co Ltd An anodyne comprising an indole acetic acid derivative,and a narcotic onarcotic or narcotic competitive analgestic compound as chief compone nts
JPS5283937A (en) * 1976-01-01 1977-07-13 Kaken Pharmaceut Co Ltd Antiphlogistic and analgesic agent containing benzoyl derivatives as e ffective component

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0648944A (ja) * 1985-12-02 1994-02-22 Du Pont Merck Pharmaceut Co 経口投与のための鎮痛剤
USRE39221E1 (en) 1991-09-06 2006-08-01 Ortho-Mcneil Pharmaceutical, Inc. Composition comprising a tramadol material and acetaminophen and its use
JP2021535216A (ja) * 2018-09-03 2021-12-16 ジェイコブ バイオテック リミテッド セバコイルジナルブフィンとアセトアミノフェンの医薬品製剤及び疼痛を治療する方法
JP2023078480A (ja) * 2018-09-03 2023-06-06 ジェイコブ バイオテック リミテッド セバコイルジナルブフィンとアセトアミノフェンの医薬品製剤及び疼痛を治療する方法

Also Published As

Publication number Publication date
HU178867B (en) 1982-07-28
CA1139671A (en) 1983-01-18
EP0019282B1 (en) 1983-01-12
DE3061597D1 (en) 1983-02-17
AU529764B2 (en) 1983-06-16
JPH0144684B2 (enExample) 1989-09-29
PH15265A (en) 1982-11-02
IL60095A (en) 1982-12-31
IL60095A0 (en) 1980-07-31
IE49988B1 (en) 1986-01-22
IE801019L (en) 1980-11-18
NZ193695A (en) 1984-05-31
ZA802916B (en) 1981-12-30
AU5835180A (en) 1980-11-20
US4237140A (en) 1980-12-02
EP0019282A1 (en) 1980-11-26

Similar Documents

Publication Publication Date Title
JPS55154917A (en) Analgesic mixture
JPS5614546A (en) Polybutyleneterephthalateecontaining mixture
JPS5630410A (en) Photopolymerizable mixture
JPS5676451A (en) Waterrsoluble polymer mixture
JPS55131030A (en) Adhesive mixture
JPS55150017A (en) Mixer
JPS5312989A (en) Waterrhardenable mixture
JPS55112261A (en) Polymer mixture
JPS5655443A (en) Poly*rhoomethylstyrene* mixture
JPS5653734A (en) Mixer
JPS5681550A (en) Novel polypeptide analgesic
GB2005688B (en) Analgesic compounds
JPS5580432A (en) Waterrsettable mixture
JPS56115332A (en) Antioxidant mixture
JPS5594318A (en) Analgesic composition
JPS54145221A (en) Synergistic mixture
JPS5620745A (en) Carburetor
GB2047534B (en) Analgesic and myotonolytic compositions
GB2055051B (en) Mixer
JPS5620746A (en) Constanttpressure carburetor
JPS5618652A (en) Dye mixture
JPS568019A (en) Mixer
JPS5655313A (en) Analgesic
JPS5649321A (en) Analgesic action mixture
GB2048701B (en) Mixing device